Management of mitochondrial-related heart disease relies on multidisciplinary care and symptom control, as targeted gene-editing therapies are limited.

According to a recent AHA Scientific Statement, despite ongoing limitations, recent advances in genomic sequencing ...

Please provide your email address to receive an email when new articles are posted on . A polygenic gout risk score was positively associated with cardiovascular disease incidence, regardless of ...

Genetic predictors of CVD are associated with increased psoriasis risk, but not vice versa. No significant associations were found between cardiovascular genetic predictors and other IMIDs. Shared ...

Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...

Genetic predisposition to gout, unfavorable lifestyle habits, and poor metabolic health are associated with an increased risk for cardiovascular disease (CVD); however, adherence to a healthy ...

Preeclampsia, gestational hypertension, and other adverse pregnancy outcomes (APOs) are known predictors of worse cardiovascular health later in life, but a new mendelian randomization study suggests ...

The addition of polygenic risk scores (PRS) improved the accuracy of the cardiovascular disease (CVD) risk prediction tool PREVENT across all groups studied, across ancestries. Over 3 million people ...

Cardiovascular diseases (CVD) cause about one in three deaths worldwide. The World Health Organization (WHO) estimates 19.8 million CVD deaths in 2022, roughly 32% of all deaths. Care remains reactive ...

Advances in genetic testing are improving the understanding of a variety of inherited cardiovascular diseases, but not all cardiologists are aware of the benefits and risks of incorporating genetic ...